| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,135 |
25,791 |
$2.14M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,036 |
3,732 |
$368K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,068 |
2,979 |
$277K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,785 |
2,667 |
$225K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,716 |
9,284 |
$221K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,028 |
1,015 |
$91K |
| 90677 |
|
590 |
573 |
$87K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
681 |
668 |
$66K |
| 90461 |
|
3,931 |
3,766 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,013 |
938 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,985 |
2,913 |
$26K |
| 92551 |
|
3,140 |
2,741 |
$22K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,004 |
3,886 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,385 |
1,288 |
$15K |
| 97802 |
|
2,105 |
2,032 |
$14K |
| 90670 |
|
1,314 |
1,166 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
288 |
263 |
$12K |
| 99381 |
|
173 |
140 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
119 |
115 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
509 |
478 |
$9K |
| 90651 |
|
317 |
258 |
$9K |
| 90686 |
|
3,888 |
3,378 |
$8K |
| 99460 |
|
156 |
140 |
$7K |
| 96127 |
|
1,519 |
1,299 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
46 |
46 |
$6K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
97 |
82 |
$6K |
| 99383 |
|
65 |
65 |
$6K |
| 99051 |
|
3,004 |
2,706 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
316 |
284 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,369 |
1,283 |
$4K |
| 90698 |
|
1,176 |
1,068 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
55 |
55 |
$3K |
| 99442 |
|
88 |
82 |
$3K |
| 83655 |
|
1,029 |
857 |
$3K |
| 90734 |
|
141 |
134 |
$3K |
| 90680 |
|
927 |
842 |
$2K |
| 90633 |
|
932 |
794 |
$2K |
| 90710 |
|
109 |
103 |
$2K |
| 99401 |
|
78 |
78 |
$2K |
| 36406 |
|
139 |
129 |
$2K |
| 36410 |
|
203 |
184 |
$2K |
| 99462 |
|
51 |
45 |
$1K |
| 96160 |
|
1,734 |
1,663 |
$1K |
| 94664 |
|
115 |
111 |
$1K |
| 96161 |
|
2,312 |
2,101 |
$1K |
| 81000 |
|
644 |
567 |
$992.29 |
| 90716 |
|
155 |
129 |
$760.11 |
| 90744 |
|
723 |
627 |
$675.77 |
| 0071A |
|
16 |
16 |
$645.85 |
| 36400 |
|
26 |
26 |
$491.38 |
| 94760 |
|
759 |
653 |
$415.83 |
| 99000 |
|
4,319 |
3,893 |
$365.51 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
71 |
65 |
$343.97 |
| 90707 |
|
139 |
112 |
$311.88 |
| 90700 |
|
103 |
94 |
$301.04 |
| 90715 |
|
61 |
55 |
$234.48 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$232.83 |
| 90696 |
|
99 |
91 |
$161.83 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
133 |
109 |
$142.71 |
| 92558 |
|
16 |
16 |
$134.05 |
| 90647 |
|
107 |
98 |
$122.13 |
| 90648 |
|
45 |
40 |
$88.76 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
102 |
84 |
$86.97 |
| 91307 |
|
38 |
33 |
$11.00 |
| 99070 |
|
56 |
56 |
$2.00 |
| 99072 |
|
126 |
121 |
$0.00 |
| 99461 |
|
20 |
14 |
$0.00 |